Programme SOM0044 for Parkinson’s Disease
SOM0044 is a small molecule for the treatment of Parkinson’s disease.
Pemazyre™ (pemigatinib) for the Treatment of Cholangiocarcinoma
Pemigatinib is an inhibitor of the fibroblast growth factor receptor (FGFR1, 2 and 3). Credit: Incyte Corporation.
Learn more
Hover over the logos to learn more about the companies who made this project possible.
Close
-
SOM Biotech
SOM Biotech is an Artificial Intelligence AI drug discovery and...
About
SOM Biotech is an Artificial Intelligence AI drug discovery and development company focused on the development of therapies for orphan indications through the proprietary AI-based drug discovery technology.
FollowMake an Enquiry
-
CSM, a Clinigen company
CSM, a Clinigen company, focuses on clinical trial supplies and...
About
CSM, a Clinigen company, focuses on clinical trial supplies and biological sample management services.
FollowMake an Enquiry
-
ACTide by Nubilaria
Nubilaria Srl is an Information Technology (IT) company founded in...
About
Nubilaria Srl is an Information Technology (IT) company founded in 1999. Our company has its origins in the design, management and distribution of complex database systems and innovative IT services under strict international security policies.
FollowMake an Enquiry